EVIO Inc (EVIO)

[fiveteenthirty]

January 29, 2018 08:03 ET | Source: Quinsam Capital Corporation
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICE

TORONTO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Quinsam Capital Corporation (“Quinsam” or the “Company”) (CSE:QCA) is pleased to announce updates on two matters and a number of new investments.

New Investments

Evio, Inc. (“Evio”): Quinsam expects to close today an investment of US$450,000 in units of convertible debentures and warrants in the capital of Evio. The debentures convert at US$0.60 and the warrants strike at US$0.80. The common shares are currently trading at approximately US$2.15. Evio is an operator of cannabis testing labs in the United States. We anticipate that Evio will pursue a Canadian listing.

About Quinsam Capital Corporation

Quinsam is a merchant bank based in Canada that is focusing on cannabis-related investments. Our merchant banking business may encompass a range of activities including acquisitions, advisory services, lending activities and portfolio investments. Quinsam invests its capital for its own account in assets, companies or projects which we believe are undervalued and where we see a viable plan for unlocking such value. We do not invest on behalf of any third party and we do not offer investment advice.

Generally, Quinsam does not believe that individual investments are material reportable events. Quinsam chooses to announce certain investments once the company is certain that it has finished buying its position because the Company feels that this information helps Quinsam’s investors understand its investment decision making process. Generally, Quinsam does not announce the sale of investments.